Phase I Study of Dasatinib (BMS-354825) and Capecitabine for Women With Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Advanced Breast Cancer
Related studies linked through entity extraction aliases.
Phase II Study With the Trifunctional Antibody Ertumaxomab to Treat Metastatic Breast Cancer Progressing After Endocrine Treatment
- Status
- TERMINATED
- Phase
- PHASE2
A Phase 1/2 Study of HKI-272 (Neratinib) in Combination With Paclitaxel (Taxol) in Subjects With Solid Tumors and Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.
- Status
- COMPLETED
- Phase
- NA
A Phase 1/2 Study Of HKI-272 (Neratinib) in Combination With Trastuzumab (Herceptin) In Subjects With Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of Larotaxel in Combination With Weekly Herceptin® in Patients With HER2 Positive Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Faslodex 500mg Multiple Dose Tolerability Study in BC Patients
- Status
- COMPLETED
- Phase
- PHASE1
Faslodex Advanced Breast Cancer Local Chinese Study
- Status
- COMPLETED
- Phase
- PHASE3
Study of Zoladex Given Every 12 Weeks Versus Given Every Month in Advanced Breast Cancer (ABC) Pre-menopausal Women
- Status
- COMPLETED
- Phase
- PHASE2
A Clinical Trial to Compare Efficacy and Tolerability of Fulvestrant 250mg, 250mg Plus 250mg Loading Regimen and 500mg
- Status
- COMPLETED
- Phase
- PHASE2
A Clinical Trial to Compare Efficacy and Tolerability of Fulvestrant 250mg, 250mg (Plus 250mg Loading Regimen) and 500mg
- Status
- COMPLETED
- Phase
- PHASE2
A Notch Signalling Pathway Inhibitor for Patients With Advanced Breast Cancer (0752-014)
- Status
- COMPLETED
- Phase
- PHASE1